Chemical Component Summary | |
---|---|
Name | 8-AZAXANTHINE |
Identifiers | 3,4-dihydro-[1,2,3]triazolo[4,5-e]pyrimidine-5,7-dione |
Formula | C4 H3 N5 O2 |
Molecular Weight | 153.099 |
Type | NON-POLYMER |
Isomeric SMILES | c12c([nH]nn1)NC(=O)NC2=O |
InChI | InChI=1S/C4H3N5O2/c10-3-1-2(8-9-7-1)5-4(11)6-3/h(H3,5,6,7,8,9,10,11) |
InChIKey | KVGVQTOQSNJTJI-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 14 |
Chiral Atom Count | 0 |
Bond Count | 15 |
Aromatic Bond Count | 10 |
Drug Info: DrugBank
DrugBank ID | DB01875 |
---|---|
Name | 8-azaxanthine |
Groups | experimental |
Synonyms |
|
Categories |
|
CAS number | 1468-26-4 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Uric acid degradation bifunctional protein | MMRLKQLNEMSASEFIHLLGGVFENSSWVAERAEPNRPYSSFQSLYNKMV... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 135400688, 15113, 5287721 |
ChEMBL | CHEMBL219341 |
ChEBI | CHEBI:40850 |
CCDC/CSD | XANAZH01 |